GLP-1 Drugs: Why So Few Are Using Them | Annapolis News

GLP-1 drugs for weight loss are exploding in popularity—nearly quadrupling in two years—but only 11% of Americans are using them, despite 70% being overweight or obese. High costs and lack of insurance coverage remain major barriers, even as supply issues fade. Brand-name drugs like Ozempic and Wegovy dominate, with no generics yet available, while compounded versions raise safety concerns. New oral forms are emerging, but experts stress these meds work best alongside lifestyle changes—or even surgery. Most users report strong results, hinting the real hurdle isn’t the drug’s effectiveness—it’s access and affordability. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/15193a94196660fc